Filing Flows › AstraZeneca (AZN) › Stock forecast & fair value
AstraZeneca (AZN) stock forecast and price target
AstraZeneca (AZN) trades at $186.43. 12 analysts' median price target is $210.00 (+13%), from $158.00 to $240.00.
AstraZeneca's latest quarter
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for AZN stock?
The median of 12 analysts' 12-month targets is $210.00, +13% from $186.43; the range is $158.00 to $240.00. The average rating is buy.
Does AstraZeneca usually beat earnings estimates?
It beat the consensus EPS estimate in 67% of the quarters on record.
Is AZN stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.